Skip to main content

Name
Kassandra Coyle

Sun, 11/15/2020 - 20:38

Thank you, Dr. Richard-Carpentier for the insightful talk and thank you, Melinda, for your excellent summary! Like my fellow classmates, I was also very intrigued by the potential of precision medicine. Further reading led me to a recent study demonstrating the success of precision medicine in treating AML. In this study, patients were enrolled in a clinical trial that aimed to provide cytogenic and mutational data, prior to treatment selection. It was found that the thirty-day mortality was less frequent and overall survival was significantly longer for patients who underwent the treatment suggested by the study as opposed to those who elected standard of care treatments. This study highlights the benefits that precision medicine can have. I look forward to continuing to follow the advancements in this field and am very optimistic about the future of precision medicine.

Burd, A. et al. Precision medicine treatment in acute myeloid leukemia using prospective genomic profiling: feasibility and preliminary efficacy of the Beat AML Master Trial. Nat. Med. (2020). doi:10.1038/s41591-020-1089-8

Name
Kassandra Coyle

Plain text

  • No HTML tags allowed.
  • Lines and paragraphs break automatically.
  • Web page addresses and email addresses turn into links automatically.